IN8bio Announces Presentation Of New Preclinical Data For Gamma-Delta NsCAR-T Cell Therapy Platform At AACR 2024; Says 'Preclinical Data Supports Potential for Proprietary NsCAR Platform to Selectively Eliminate Cancer Cells While Preserving Healthy Tissue'
in8bio宣佈在2024年的AACR上公佈伽瑪-德爾塔NSCAR-T細胞療法平台的新臨床前數據；表示 “臨床前數據支持專有NSCAR平台在保護健康組織的同時有選擇地消滅癌細胞的潛力”